Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 ...

Wegovy ® will be the preferred GLP-1 medicine for obesity on the largest commercial template formularies for CVS Caremark, the largest Pharmacy Benefit Manager (PBM) in the US, effective July 1 ...

will soon be the preferred GLP-1 medicine on its largest commercial template formularies. This change will be effective July 1, 2025. "We believe in the unique benefits of Wegovy ® and the ...

WASHINGTON, May 1, 2025 /PRNewswire/ -- With mounting evidence that an infodemic of disinformation about GLP-1 weight loss medicines has become America's second obesity crisis, the National Consu ...

Eli Lilly and Compnay (NYSE:LLY), known for its diabetes and weight-loss drugs, was mentioned at the time due to a strong earnings report driven by soaring demand for its GLP-1 medications.

Gen Alpha (children 14 and younger) led the rise of GLP-1 utilization from 2023 to 2024, with an 85% growth rate in that period. But what is behind the sharp increase? 3 factors at play There are ...

For many, the big question is whether the pricey medications known as GLP-1s will pay off by improving worker health and lowering overall health costs over time. Analysts at Aon say it's already ...

After taking legal action against the companies making and distributing compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were ...